Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE2
Tocilizumab in Coronavirus-19 Positive Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
- Status
- TERMINATED
- Phase
- PHASE3
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
- Status
- SUSPENDED
- Phase
- NA
Randomised Evaluation of COVID-19 Therapy
- Status
- RECRUITING
- Phase
- PHASE3
The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
- Status
- UNKNOWN
- Phase
- PHASE4
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
- Status
- TERMINATED
- Phase
- PHASE2
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE3
Tocilizumab for Patients With Cancer and COVID-19 Disease
- Status
- TERMINATED
- Phase
- PHASE2
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
- Status
- WITHDRAWN
- Phase
- PHASE3
Efficacy of Tocilizumab on Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy of Early Administration of Tocilizumab in COVID-19 Patients
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression
- Status
- UNKNOWN
- Phase
- PHASE3